thiazoles has been researched along with pirarubicin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Endo, Y; Kimura, H; Kinoshita, K; Miyazaki, I; Ninomiya, I; Ohyama, S; Sasaki, T; Tanaka, M; Tugawa, K; Yonemura, Y | 1 |
Furusawa, S; Nakano, S; Sasaki, K; Takayanagi, M; Takayanagi, Y; Wu, J | 1 |
Bedenne, L; Beltramo, JL; Cercueil, JP; Chauffert, B; Cognet, F; Faure, P; Favoulet, P; Isambert, N; Krause, D; Osmak, L | 1 |
Isogawa, Y; Kakehi, Y; Kamoto, T; Kinoshita, H; Mizutani, Y; Ogawa, O; Terachi, T; Wu, XX | 1 |
4 other study(ies) available for thiazoles and pirarubicin
Article | Year |
---|---|
[Chemosensitivity test for gastric cancer by in vitro MTT assay].
Topics: Antineoplastic Agents; Carbazilquinone; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Fluorouracil; Humans; Mitomycin; Mitomycins; Stomach Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1991 |
Potentiation of pirarubicin activity in multidrug resistant cells by rifampicin.
Topics: Animals; Antibiotics, Antineoplastic; Antibiotics, Antitubercular; Apoptosis; Cell Cycle; Doxorubicin; Drug Resistance, Multiple; Drug Synergism; Gene Expression Regulation, Neoplastic; Genes, MDR; Leukemia P388; Mice; Rifampin; Tetrazolium Salts; Thiazoles | 1997 |
Increased cytotoxicity and stability of Lipiodol-pirarubicin emulsion compared to classical doxorubicin-Lipiodol: potential advantage for chemoembolization of unresectable hepatocellular carcinoma.
Topics: Amiodarone; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chromatography, High Pressure Liquid; Doxorubicin; Drug Resistance, Multiple; Drug Stability; Emulsions; Enzyme Inhibitors; Humans; Iodized Oil; Liver Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2001 |
Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer.
Topics: Acridine Orange; Anthracyclines; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Caspase 6; Caspase 8; Caspase 9; Caspases; Coloring Agents; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Humans; Immunohistochemistry; Male; Membrane Glycoproteins; Prostatic Neoplasms; Recombinant Proteins; Tetrazolium Salts; Thiazoles; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |